health flash

April 2007
Self;Apr2007, Vol. 29 Issue 4, p162
The article offers newsbriefs related to health in the U.S. The Centers for Disease Control and Prevention advised to scrub hands with soap and water for at least 20 seconds to remove germs and dirts while a new study from the Harvard School of Public Health discovers that nicotine content in cigarettes has risen about 11% over seven years. In addition, the first Food and Drug Administration-approved chewable oral contraceptive Femcon Fe is already available.


Related Articles

  • Acambis Wins FDA Approval For New Smallpox Vaccine. Moran, Nuala // BioWorld International;9/5/2007, Vol. 12 Issue 36, p1 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved Acambis plc's smallpox vaccine ACAM 2000. The vaccine is the first new biodefense vaccine to be licensed since the U.S. government launched Project Bioshield in 2001. Acambis CEO Ian Garland claims that the...

  • Conjugate Pneumococcal Vaccine and Adults. Deresinski, Stan // Internal Medicine Alert;7/29/2012, Vol. 34 Issue 14, p109 

    Synopsis: While Prevnar 13 has received FDA approval for use in adults aged 50 years and older, the CDC recommends continued use of the 23-valent polysaccharide pneumococcal vaccine until further information becomes available.

  • First I.V. neuraminidase inhibitor approved to treat influenza. TANZI, MARIA G. // Pharmacy Today;Feb2015, Vol. 21 Issue 2, p38 

    The article focuses on the approval of BioCryst Pharmaceuticals Inc.'s peramivir (Rapivab) by the U.S. Food and Drug Administration (FDA). The drug is for the treatment of acute uncomplicated influenza in adult patients who have not been symptomatic for more than 2 days. Information about...

  • FDA Moves Quickly on Narcan Nasal Spray.  // NoDak Pharmacy;Dec2015, Vol. 28 Issue 5, p14 

    The article discusses the approval of the Narcan nasal spray by the U.S. Food and Drug Administration (FDA). Topics discussed include a report from the U.S. Centers for Disease Control and Prevention on rise in number of drug overdose deaths in the U.S., the views of FDA's acting commissioner...

  • Hemispherx Files Ampligen NDA: First Therapy For CFS? Osborne, Randall // BioWorld Today;10/12/2007, Vol. 18 Issue 199, p1 

    The article reports on the filing of a new drug application by Hemispherx Biopharma Inc. for Ampligen that could lead to the first approved toll-like receptor-based therapy and the first drug cleared by the U.S. Food & Drug Administration for chronic fatigue syndrome (CFS). The condition was...

  • Pre-exposure prophylaxis for HIV prevention under review by Food and Drug Administration.  // Contraceptive Technology Update;Jul2012 STI Quarterly, p1 

    The article reports on a 2012 decision which the U.S. Food and Drug Administration made to approve the drug Truvada, in conjunction with condoms and other safe sex measures, for the prevention of HIV in individuals at risk of acquiring the virus through sexual activity.

  • FDA actions. Elliott, William T. // Infectious Disease Alert;Mar2013 Pharmacology Watch, p2 

    The article discusses drug regulatory actions of the U.S. Food and Drug Administration (FDA). The proposed move of hydrocodone/acetaminophen from schedule III to schedule II by an FDA advisory committee was supported by the American Academy of Pain Medicine. The FDA has given approval to the...

  • Influenza Season Vaccines for 2010-2011 Approved By the FDA.  // O&P Business News;9/1/2010, Vol. 19 Issue 10, p48 

    The article reports on the announcement from the U.S. Food and Drug Administration (FDA) that the vaccines recommended by its Vaccines and Related Biological Products Advisory Committee has been approved. It states that seasonal influenza vaccine defend against all three variants including the...

  • New Medication for Severe Malaria Available under an Investigational New Drug Protocol.  // Clinical Infectious Diseases;10/1/2007, Vol. 45 Issue 7, piii 

    The article reports that the U.S. Centers for Disease Control and Prevention's (CDC's) Investigational New Drug Application (IND) for intravenous artesunate went into effect on June 21, 2007. Under a protocol entitled "Intravenous Artesunate for Treatment of Severe Malaria in the United States,"...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics